Carbonium Core

Carbonium is a Cambridge-based biotechnology company focused on advancing small molecule drug discovery through its proprietary Carbonium Core platform. The company leverages a combination of quantum mechanics, machine learning, and high-performance computing to model complex molecular interactions with unprecedented precision. By focusing on the electronic and structural nuances of the carbonium state, the platform enables the design of novel therapeutics for targets previously considered undruggable. Carbonium is led by a team of experts in computational chemistry, including veterans from Relay Therapeutics. The company is currently in the pre-clinical stage and is operating in stealth to build a pipeline of precision medicines. Its approach aims to significantly reduce the time and cost associated with traditional drug development cycles.